Janssen: A Multicenter, Randomized, Placebo Controlled, Double-Blind Study to Investigate the Safety, Tolerability, and Clinical Efficacy of Seltorexant (JNJ-42847922) on Behavioral and Psychological Symptoms of Dementia in Patients with...

Project: Research

Status	Finished
Effective start/end date	02/5/24 → 02/4/25

Project Details